/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Direct Attack
3.2.21, 5:23 PM EST on neoscope
Study: COVID-19 Can Kill Heart Cells
Reckless
3.2.21, 5:15 PM EST on neoscope
Despite Rebounding Cases of COVID, TX to Open State "100 Percent"
Get Vaccinated
Updated 3.2.21, 4:05 PM EST on neoscope
Catholic Archdiocese Calls COVID Vaccine "Morally Compromised"
Mask Up
3.2.21, 1:20 PM EST on neoscope
New P.1 Strain Can Re-Infect People Who Already Caught COVID
Special Pass
Updated 3.2.21, 12:49 PM EST on neoscope
Expert: Vaccination Passports Could Become a "Dystopian Nightmare"
Mission Complete
3.1.21, 4:28 PM EST on neoscope
Paralyzed Man Walks More Than 100 Miles in Powered Exoskeleton
Head Tattoos
3.1.21, 3:54 PM EST on neoscope
This Startup Wants to Tattoo Brain-Reading Electrodes on Your Skull
Please Focus
3.1.21, 2:56 PM EST on neoscope
Surgeon Contests Traffic Ticket While Operating on Patient
Manhunt
Updated 3.1.21, 12:09 PM EST on neoscope
Officials Hunting For Missing Person Infected With New COVID Strain
The Rat Race
2.28.21, 12:42 PM EST on neoscope
Study: Social Media Turns Us Into Hungry Rats Basically
Stalling For Time
2.28.21, 11:45 AM EST on neoscope
U.S. COVID Case Decline Has Stalled, Researchers Warn
Zoom Out
2.27.21, 2:02 PM EST on neoscope
Study: "Zoom Fatigue" Exists—and It Totally Sucks
  • Previous
  • 1
  • ...
  • 136
  • 137
  • 138
  • ...
  • 217
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.